Portfolio (Quarterly)
Guide ↗
SAMSARA BIOCAPITAL, LLC
· CIK 0001744967| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IVA | INVENTIVA SA | Healthcare | 5,194,805.0 | $24.2M | 2.49% | NEW | — | $4.65 | +9.0% |
| 2 | RANI | RANI THERAPEUTICS HLDGS INC | Healthcare | 8,500,000.0 | $11.5M | 1.18% | NEW | — | $1.35 | -20.7% |
| 3 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 1,960,000.0 | $7.8M | 0.81% | NEW | — | $4.00 | +1.0% |
| 4 | — | SUTRO BIOPHARMA INC | — | 204,503.0 | $2.4M | 0.24% | NEW | — | $11.57 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%